Status:
COMPLETED
Management Radiodermatitis in Patients With Breast or Head and Neck Cancer
Lead Sponsor:
University of Brasilia
Conditions:
Radiodermatitis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
It aims to evaluate the efficacy of the chamomile recutita gel and urea cream in the prevention of radiodermatitis in patients with breast cancer or head and neck cancer undergoing radiotherapy. Prop...
Detailed Description
It is considered that patients undergoing radiotherapy in use gel based on C. recutita or use of cream based urea three times a day, concomitant radiotherapy, would present the following hypotheses: ...
Eligibility Criteria
Inclusion
- Being an adult, over the age of 18 years old;
- Owning diagnosis of malignant breast or head and neck;
- Being first referred to the radiotherapy protocol;
- Agree to participate, expressing his acceptance by signing the Informed Consent Form (ICF);
- Present absence of dermatitis to initiation of radiotherapy;
- Demonstrate understanding of and conditions to continue the intervention in their home environment when needed.
Exclusion
- Reports of previous hypersensitivity reaction or presentation, during the research, adverse reaction to chamomile or any plant of the Asteraceae or compositae family, or urea;
- Medical prescription for the procedure of data collection, some kind of intervention to prevent radiodermatitis;
- Withdrawal of the patient to remain in the study, independent of time.
Key Trial Info
Start Date :
July 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2017
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT02247830
Start Date
July 1 2015
End Date
July 1 2017
Last Update
October 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Brasília
Brasília, Brazil